Our Leadership

Sylvain joined Crohn's and Colitis Canada as interim President and CEO in January 2025, and has worked in the healthcare industry his entire career, starting in the pharmaceutical sector, later holding President positions for both a medical device and a dental company. He has global experience, as he was responsible for the Americas and Australia/New Zealand, and helped launch multiple products in Europe. Sylvain also had full P&L responsibilities while being an active member of a culture transformation committee as part of an Americas Leadership Team. Since his retirement, he has been involved in Board and Advisory work. Sylvain was on the Crohn's and Colitis Canada board of directors for over six years and was an active member of the Governance and Nominating, as well as the Finance, Audit and Risk committees.

Sylvain has been volunteering at the Ostomy Youth Camp in Calgary and helped raise funds for mental health and other initiatives. As part of his work with a leading medical device company, Sylvain has been exposed to the challenges and resilience demonstrated by individuals living with IBD. Sylvain looks forward to the opportunity of contributing to this important cause.

Shawna joined Crohn’s and Colitis Canada in January 2023. A strategic healthcare and non-profit leader, Shawna brings senior expertise in leading mission-critical strategic and governance processes that transform organizations.  Most recently, Shawna led the planning, development and implementation of a ground-breaking new strategic and impact framework for the MS Society of Canada providing greater clarity and impact for the MS community. Previously, Shawna worked at Sunnybrook Health Sciences Centre and Public Health Ontario developing and implementing transformational strategic initiatives, establishing policy and process frameworks, and cultivating key partnerships to shape the organizations.  
 
With a passion for creating positive change, Shawna looks forward to contributing her expertise to Crohn’s and Colitis Canada. 

Kate Lee is Vice President of Research & Patients Programs at Crohn’s and Colitis Canada, where she oversees the organization’s research, patient and advocacy programs to find the cure(s) and improve the quality of life of everyone affected by Crohn’s disease and ulcerative colitis. Kate has almost 20 years of experience in the health sector, including Managing Director of the Canadian Arthritis Network - a Centre of Excellence funded by the tri-council funding agencies of CIHR, NSERC and SSHRC, VP of Research at the Arthritis Society, and as a scientist at a biotech company. Kate holds a PhD in biology from McGill University and an MBA from Rotman School of Management University of Toronto.

Kate is an avid gardener and loves exploring new restaurants whenever possible.